Research suggests peer support programs that may have been developed to support clinicians following an adverse event or medical error also be leveraged to help those suffering from stress, anxiety, or other emotional difficulties following incidents of workplace violence.
No knew the world would be in the grips of COVID-19 in 2016. That is when Johns Hopkins Hospital unveiled a first-of-its-kind Capacity Command Center (CCC), a high-tech control room designed to apply all the latest analytical tools to bed management, patient transfers, and surge planning. CCC leaders have spent the last five years working around the clock to optimize patient flow and anticipate any potential bottlenecks. But there is no question the concept has been put to the test by pandemic conditions. How did it fare?
Recognizing that EDs are uniquely positioned to engage patients with opioid use disorder into effective treatment, Pennsylvania officials decided to test whether financial incentives would be enough to nudge hospitals to facilitate stronger action.
Most of data supporting the pulmonary embolism response team (PERT) concept comes from single-center reports that lack prospective, controlled studies to evaluate the benefits. PERTs are so prevalent today that it is doubtful researchers could conduct a randomized, clinical trial. To surmount this hurdle, researchers are endeavoring to bring everyone’s data together in one multicenter registry called the PERT Consortium Quality Database.
Emergency clinicians are adept at diagnosing and treating pulmonary embolisms. In cases deemed intermediate- or high-risk, determining which treatment is best is not always clear. Innovators at Massachusetts General Hospital developed the first pulmonary embolism response team, which has since been adopted widely.
Part I of this article reviewed nonpenetrating ocular trauma that presents a severe threat to vision. Part II will discuss potential vision threats of nonpenetrating ocular trauma, including burns, corneal abrasions, corneal foreign bodies, and hyphemas.
In this randomized clinical trial, hypertonic saline given via rapid intermittent bolus therapy was as effective and safe as slow continuous infusion, and was associated with a lower rate of recorrecting treatment and higher efficacy in achieving goal sodium within one hour.
By shortening the duration of antibiotic therapy, a procalcitonin-guided protocol decreased the rate of infection-associated adverse effects, decreased costs, and reduced mortality in patient with sepsis.